[go: up one dir, main page]

ES2115975T3 - Derivados de triariletileno utilizados terapeuticamente. - Google Patents

Derivados de triariletileno utilizados terapeuticamente.

Info

Publication number
ES2115975T3
ES2115975T3 ES94927182T ES94927182T ES2115975T3 ES 2115975 T3 ES2115975 T3 ES 2115975T3 ES 94927182 T ES94927182 T ES 94927182T ES 94927182 T ES94927182 T ES 94927182T ES 2115975 T3 ES2115975 T3 ES 2115975T3
Authority
ES
Spain
Prior art keywords
used therapeutically
derivatives used
triarylethylene
triarylethylene derivatives
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94927182T
Other languages
English (en)
Inventor
Donald P Matthews
Alan J Bitonti
Sickle William A Van
Donald A Kaplan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/259,797 external-priority patent/US5525633A/en
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2115975T3 publication Critical patent/ES2115975T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVOS DERIVADOS DE TRIARILETILENO QUE CON UTILES COMO AGENTES ANTINEOPLASICOS, AGENTES ANTIATEROSCLEROTICOS Y AGENTES HIPOCOLESTEROLEMICOS.
ES94927182T 1993-09-24 1994-08-19 Derivados de triariletileno utilizados terapeuticamente. Expired - Lifetime ES2115975T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12661493A 1993-09-24 1993-09-24
US08/259,797 US5525633A (en) 1993-09-24 1994-06-15 Triaryl-ethylene derivatives

Publications (1)

Publication Number Publication Date
ES2115975T3 true ES2115975T3 (es) 1998-07-01

Family

ID=26824862

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94927182T Expired - Lifetime ES2115975T3 (es) 1993-09-24 1994-08-19 Derivados de triariletileno utilizados terapeuticamente.

Country Status (17)

Country Link
US (1) US5684004A (es)
EP (1) EP0720597B1 (es)
JP (1) JPH09503761A (es)
CN (1) CN1131415A (es)
AT (1) ATE165594T1 (es)
AU (1) AU678535B2 (es)
CA (1) CA2171728C (es)
DE (1) DE69409961T2 (es)
DK (1) DK0720597T3 (es)
ES (1) ES2115975T3 (es)
FI (1) FI961339A7 (es)
HU (1) HUT75933A (es)
IL (1) IL111018A0 (es)
NO (1) NO306292B1 (es)
NZ (1) NZ273433A (es)
PL (1) PL177833B1 (es)
WO (1) WO1995008528A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
CN110075069A (zh) 2009-05-06 2019-08-02 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其应用
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1099093A (en) * 1965-09-03 1968-01-17 Ici Ltd Alkene derivatives
EP0002097B1 (en) * 1977-08-22 1981-08-05 Imperial Chemical Industries Plc Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NO306292B1 (no) 1999-10-18
ATE165594T1 (de) 1998-05-15
FI961339A0 (fi) 1996-03-22
FI961339L (fi) 1996-03-22
AU678535B2 (en) 1997-05-29
HU9600727D0 (en) 1996-05-28
EP0720597B1 (en) 1998-04-29
NZ273433A (en) 1997-11-24
WO1995008528A1 (en) 1995-03-30
NO961204L (no) 1996-03-25
JPH09503761A (ja) 1997-04-15
EP0720597A1 (en) 1996-07-10
PL177833B1 (pl) 2000-01-31
DK0720597T3 (da) 1998-10-07
IL111018A0 (en) 1994-11-28
US5684004A (en) 1997-11-04
FI961339A7 (fi) 1996-03-22
CA2171728C (en) 2001-11-13
AU7670794A (en) 1995-04-10
CA2171728A1 (en) 1995-03-30
CN1131415A (zh) 1996-09-18
NO961204D0 (no) 1996-03-25
DE69409961D1 (de) 1998-06-04
DE69409961T2 (de) 1998-09-10
PL313594A1 (en) 1996-07-08
HUT75933A (en) 1997-05-28

Similar Documents

Publication Publication Date Title
HN1997000126A (es) Derivados de indazol
HN1995009160A (es) Derivados de cicloalcano indol y azaindol
HN1998000086A (es) Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000124A (es) Terapia de combinacion
HN1998000132A (es) Combinaciones terapeuticas
HN1998000168A (es) Derivados de la tienapirimidina y de la tienapiridina utiles como agentes anticancerigenos.
HN1997000023A (es) Derivados de lactama
HN1998000011A (es) Derivados de acidos arilsulfonilaminohidroxamicos
HN1997000012A (es) Derivados de triazol utiles en terapia.
HN1998000036A (es) Compuesto de pirazina
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
HN1998000139A (es) Pirimidin-4-ona y pirimidin-4-tiona novedosas como funguicidas
ES2098140T3 (es) Liosferas que contienen gonadotropina.
HN1997000146A (es) Derivados de pirimidina biciclica condensada
HN1997000097A (es) Piridinas condensadas con heterociclicos
PA8436201A1 (es) Derivados 6,5-heterobiciclicos sustituidos
ES2195970T3 (es) L-ribavirina y usos de la misma.
HN1998000115A (es) Formas de dosificación farmacéuticas sólidas
HN1998000118A (es) 2 - aminopiridinas que contienen sustituyentes de anillos condensados.
HN1997000090A (es) Compuestos de piridilpirrol
HN1998003689A (es) Azetidinas
ES2119203T3 (es) Derivados de poliamina n-alquiltio utilizados como agentes radioprotectores.
HN1998000028A (es) Otropisomeros de 3 heteroaril - 4 (3h) - quinazolinonas.
HN1998000199A (es) Agentes terapeuticos
CO4230021A1 (es) Glicosidos esteroideos, procedimientos de uso de los mismos como agentes hipocolesterolemicos y agentes antiateroscle- roticos en mamiferos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 720597

Country of ref document: ES